Gilder Gagnon Howe & Co’s Hims & Hers Health HIMS Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.64M	Buy	133,921 +3,968	+3%	+$107K	0.05%	173
2026 Q1	$2.7M	Sell	129,953 -24,079	-16%	-$569K	0.03%	184
2025 Q4	$5M	Sell	154,032 -1,055	-0.7%	-$45.2K	0.05%	152
2025 Q3	$8.8M	Buy	155,087 +4,346	+3%	+$223K	0.09%	123
2025 Q2	$7.51M	Buy	150,741 +169	+0.1%	+$7.64K	0.08%	126
2025 Q1	$4.45M	Sell	150,572 -11,451	-7%	-$425K	0.06%	139
2024 Q4	$3.92M	Sell	162,023 -6,589	-4%	-$163K	0.04%	158
2024 Q3	$3.11M	Sell	168,612 -28,741	-15%	-$515K	0.04%	167
2024 Q2	$3.98M	Buy	197,353 +308	+0.2%	+$5.13K	0.05%	153
2024 Q1	$3.05M	Buy	197,045 +14,543	+8%	+$164K	0.04%	173
2023 Q4	$1.62M	Buy	182,502 +13,377	+8%	+$98.9K	0.02%	189
2023 Q3	$1.06M	Sell	169,125 -949	-0.6%	-$7.06K	0.02%	209
2023 Q2	$1.6M	Buy	170,074 +84,388	+98%	+$837K	0.02%	205
2023 Q1	$850K	Buy	+85,686	New	+$751K	0.01%	201

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Gilder Gagnon Howe & Co's HIMS Position: Q2 2026 in Review

Gilder Gagnon Howe & Co increased its Hims & Hers Health (HIMS) stake by 3.1% in Q2 2026, buying an estimated $107K and bringing the position to 133,921 shares worth $4.64M. The position accounts for 0.05% of the portfolio, ranked #173.

Gilder Gagnon Howe & Co first reported a position in HIMS in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.8M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Gilder Gagnon Howe & Co held 133,921 shares of Hims & Hers Health worth $4.64M as of Q2 2026.
Gilder Gagnon Howe & Co bought 3,968 Hims & Hers Health shares in Q2 2026, an estimated $107K.
Hims & Hers Health made up 0.05% of Gilder Gagnon Howe & Co's portfolio in Q2 2026, its #173 holding.
Gilder Gagnon Howe & Co first reported a position in Hims & Hers Health in Q1 2023 and has held it in 14 quarters since.
Gilder Gagnon Howe & Co's Hims & Hers Health position peaked at $8.8M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.